Global Appetite Stimulant Market – Industry Trends and Forecast to 2030

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

Global Appetite Stimulant Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Appetite Stimulant Market

市场规模(十亿美元)

CAGR :  % Diagram

Chart Image USD 1.00 Billion USD 1.57 Billion 2022 2030
Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1.00 Billion
Diagram Market Size (Forecast Year)
USD 1.57 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Global Appetite Stimulant Market, By Types (Megestrol Acetate, Oxandrolone, Dronabinol, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Appetite Stimulant Market

Appetite Stimulant Market​​​​​​​ Analysis and Size

Even though it is not a new disease, an appetite disorder can be associated with modern lifestyle. Several manufacturers specifically promote their medications to increase appetite. Minerals, Vitamins, and herbs may also act as orexigenics, which can make lifestyle and dietary changes. The incidence of mental disorders that can cause anxiety and stress among the population and rise in the occurrence of eating disorders among women boost the market growth. 

Data Bridge Market Research analyses that the appetite stimulant market is expected to reach USD 1.57 billion by 2030, which is USD 1 billion in 2022, and is expected to undergo a CAGR of 5.80% during the forecast period 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Appetite Stimulant Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Types (Megestrol Acetate, Oxandrolone, Dronabinol, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Novartis AG (Switzerland), Sanofi (France), Pfizer Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Bausch Health Companies Inc. (Canada), AstraZeneca (U.K.), GSK plc (U.K.), Abbvie, Inc (U.S.), Apotex Inc (Canada), Lilly (U.S.)

Market Opportunities

  • Wide Availability of Appetite Stimulants

Market Definition

An appetite stimulant or orexigenic is a drug, compound, or hormone which helps in improving appetite and may induce hyperphagia. The product could be a medicine or a naturally occurring neuropeptide hormone, such as neuropeptide orexin, or ghrelin which improves food consumption. Some vitamins and minerals, including zinc and vitamin B-1, can increase appetite. Though, these typically only work if the person has deficiencies in these nutrients.

Appetite Stimulant Market Dynamics

Drivers

  • Rising Incidence of Appetite Disorders

The rising incidences of appetite disorders increase the growth of the market. Females are more susceptible to eating or appetite disorders compared to men. As per an article published in Psychology Today, about 0.5% to 3.7% of the female population suffers from anorexia nervosa while, an estimated 1.1% to 4.2% of the female population have bulimia nervosa in their lifetime. In the U.S., around 7 million women and 1 million men suffer from appetite disorders. Thus this boost the need for appetite stimulants

Opportunities

  • Wide Availability of Appetite Stimulants

Certain vitamins and minerals, which includes zinc and vitamin B-1, can increase appetite. Zinc deficiency can cause typical symptoms such as loss of appetite and poor immune function. It may also cause changes in slow healing, taste perception, and hair loss. Taking zinc supplements may stimulate appetite in people having zinc deficiencies. Omega-3 fatty acids are the necessary healthy fats in the human diet. Some research advises that marine-based omega-3 fats may increase appetite and a person’s desire to eat. Also, fish oil and fatty fish such as salmon are the major sources of omega-3 fatty acids. Vegetarians and vegans are now drifting towards algae based omega-3 supplements. It has been seen that naturopathy may recommend bitter tasting herbs to people who want to improve their appetite or digestion.

Restraints/Challenges

  • Late Approvals from Organizations

Numerous companies from different organizations cannot manufacture a drug unless a drug's patent stops. Thus, there are numerous chances that make the billion dollar drugs lose patents. This impedes the market growth.

This appetite stimulant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the appetite stimulant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Appetite Stimulant Market Scope

The appetite stimulant market is segmented on the basis of types, distribution channel, end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

  • Megestrol Acetate
  • Oxandrolone
  • Dronabinol
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

End-User

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Appetite Stimulant Market Regional Analysis/Insights

The appetite stimulant market is analyzed and market size insights and trends are provided by types, distribution channel, end users as referenced above.

The major countries covered in the appetite stimulant market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period because of the presence of developed healthcare infrastructure within the region. 

Asia-Pacific is considered to have the most lucrative period because of the increased awareness of the various appetite disorders.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Appetite Stimulant Market Share Analysis

The appetite stimulant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to appetite stimulant market.

Key players operating in the appetite stimulant market include:

  • Novartis AG (Switzerland)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Abbott (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bausch Health Companies Inc. (Canada)
  • AstraZeneca (U.K.)
  • GSK plc (U.K.)
  • Abbvie, Inc (U.S.)
  • Apotex Inc (Canada)
  • Lilly (U.S.)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 , By Types (Megestrol Acetate, Oxandrolone, Dronabinol, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030. 进行细分的。
在2022年,Global Appetite Stimulant Market的规模估计为1.00 USD Billion美元。
Global Appetite Stimulant Market预计将在2023年至2030年的预测期内以CAGR 5.8%的速度增长。
该市场报告涵盖U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America的数据。
Testimonial